Medical Marijuana, Inc. Announces Its Cannabis Drug Research and Drug Development Pipeline Update
MJNA’s Investments Support Development of New Cannabis-Based Medications and Delivery Methods; Developments Further the Reintroduction of Cannabis Medications GloballyMedical Marijuana, Inc. (OTC: MJNA) is pleased to announce that the “Company of Firsts” investments are actively fostering cannabis-based drug development and creation of new, innovative medicine delivery methods. These results are intended to expedite the historic reintroduction of cannabis-based medications into U.S. and global healthcare systems. Medical Marijuana, Inc. is placing its